Flow cytometric analysis of P-glycoprotein in normal and leukemic cells
- PMID: 1356449
- DOI: 10.1007/BF01695811
Flow cytometric analysis of P-glycoprotein in normal and leukemic cells
Abstract
Classical multidrug resistance is characterized by overexpression of a membrane protein, P-glycoprotein, which acts like a drug-extruding pump, reducing accumulation of cytotoxic drugs inside malignant cells. We have developed a simple method for detecting an intracellular epitope of P-glycoprotein in normal and leukemic cells by the monoclonal antibody JSB-1 and fluorescence-activated flow cytometry. Permeabilization of blood and bone marrow cells in unprocessed samples is achieved by a commercially available red blood cell lysing solution which excellently preserves the light scatter properties of leukocytes. The method is suitable for analyzing samples in clinical routine. Lower than 1% reactivity was seen in the lymphoid gate of normal peripheral blood and bone marrow samples as compared with over 60% of reacting cells in some leukemic samples. Twelve patients with acute de novo leukemia were studied at presentation, 13 patients at a refractory stage, and 28 in remission. There was a positive correlation between the P-glycoprotein and the CD34 expression in acute myelogenous leukemia and an association between the P-glycoprotein expression and the blast count in both acute myelogenous and lymphatic leukemias.
Similar articles
-
Detection of P glycoprotein activity on normal and leukemic CD34+ cells.Leuk Res. 1993 Dec;17(12):1031-5. doi: 10.1016/0145-2126(93)90159-i. Leuk Res. 1993. PMID: 7504150
-
Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine.J Natl Cancer Inst. 1990 Jul 4;82(13):1133-40. doi: 10.1093/jnci/82.13.1133. J Natl Cancer Inst. 1990. PMID: 1972761
-
New flow cytometric method for detection of minimally expressed multidrug resistance P-glycoprotein on normal and acute leukemia cells using biotinylated MRK16 and streptavidin-RED670 conjugate.Jpn J Cancer Res. 1995 Jun;86(6):607-15. doi: 10.1111/j.1349-7006.1995.tb02441.x. Jpn J Cancer Res. 1995. PMID: 7622426 Free PMC article.
-
Multidrug resistance.Ann Med. 1991;23(5):509-20. doi: 10.3109/07853899109150511. Ann Med. 1991. PMID: 1684512 Review.
-
Expression of MDR1 by normal bone marrow cells and its implication for leukemic hematopoiesis.Leuk Lymphoma. 1995 Feb;16(5-6):419-24. doi: 10.3109/10428199509054428. Leuk Lymphoma. 1995. PMID: 7540457 Review.
Cited by
-
Multidrug resistance in cancer chemotherapy.Invest New Drugs. 1994;12(1):1-13. doi: 10.1007/BF00873229. Invest New Drugs. 1994. PMID: 7960599 Review.
-
P-glycoprotein-mediated multidrug resistance in normal and neoplastic hematopoietic cells.Ann Hematol. 1994 Oct;69(4):159-71. doi: 10.1007/BF02215949. Ann Hematol. 1994. PMID: 7948302 Review.
-
P-glycoprotein expression and regulation. Age-related changes and potential effects on drug therapy.Drugs Aging. 1995 Jul;7(1):19-29. doi: 10.2165/00002512-199507010-00003. Drugs Aging. 1995. PMID: 7579778 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials